News/ UK & Europe Celgene’s Revlimid gets new EU use Richard Staines cancer, Celgene, lymphatic 0 Comment Flagship drug approved in rare lymphatic cancer. Share X Celgene’s Revlimid gets new EU use https://pharmaphorum.com/news/celgenes-revlimid-gets-new-eu-use/
cancer, Celgene, lymphatic
0 Comment
